HCA HCA Healthcare, Inc. Common Stock

NYSE · Health Care · Ver em SEC EDGAR ↗
$420,53
Preço · Ago 19, 2026
Fundamentais a partir de Jul 28, 2026

Sobre HCA Healthcare, Inc. Common Stock Visão geral da empresa da Wikipedia

HCA Healthcare, Inc. is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.

Ler mais

HCA Healthcare, Inc. (historically known as Hospital Corporation of America) is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.

History

Early years

The Hospital Corporation of America (HCA) was founded in 1968 in Nashville, Tennessee, by Thomas F. Frist Sr., Thomas F. Frist Jr. and Jack C. Massey. The founders envisioned a company that would bring together hospitals to deliver patient-focused care while using the combined resources of the organization to strengthen hospitals and improve the practice of medicine. The company began with Nashville's Park View Hospital, which the elder Frist had founded in 1960 with other doctors and where he was serving as chief executive.

The company included 11 hospitals when it filed its initial public offering on the New York Stock Exchange (NYSE) in 1969 and had 26 hospitals and 3,000 beds by the end of the year.

Growth and merger

The 1970s were characterized by rapid growth in the industry and for HCA Healthcare. In the early 1980s, the focus shifted to consolidation with HCA Healthcare acquiring General Care Corporation, General Health Services, Hospital Affiliates International and Health Care Corporation. By the end of 1981, the company operated 349 hospitals with more than 49,000 beds. Operating revenues had grown to $2.4 billion.

In 1987, HCA Healthcare, which had grown to operate 463 hospitals (255 owned and 208 managed), spun off HealthTrust, a privately owned, 104-hospital company. Believing its stock was undervalued, the company completed a $5.1 billion leveraged management buyout led by chairman Thomas F. Frist Jr. in 1988. HCA Healthcare re-emerged as a public company in 1992.

In February 1994, HCA Healthcare merged with Louisville, Kentucky-based Columbia Hospital Corporation, which earlier had acquired 73 hospitals of Galen Health Care from Humana,

to form Columbia/HCA Healthcare Corporation. Related names of note include HCA International and Health Corporation of America.

Columbia Hospital Corporation

In 1988, Rick Scott and Richard Rainwater each put up $125,000 in working capital in their new company, Columbia Hospital Corporation; they borrowed the remaining money needed to purchase two struggling hospitals in El Paso for $60 million. Then they acquired a neighboring hospital and shut it down. Within a year, the remaining two were doing much better. By the end of 1989, Columbia Hospital Corporation owned four hospitals with a total of 833 beds.

In 1992, Columbia made a stock purchase of Basic American Medical, which owned eight hospitals, primarily in southwestern Florida. In September 1993, Columbia did another stock purchase, worth $3.4 billion, of Galen Healthcare, which had been spun off by Humana Inc. several months earlier. At the time, Galen had approximately 90 hospitals. After the purchase, Galen stockholders had 82% of the stock in the combined company, with Scott still running the company.

Recent history

On November 17, 2006, HCA became a private company for the third time when it completed a merger in which the company was acquired by a private investor group including affiliates of Kohlberg Kravis Roberts and Bain Capital, together with Merrill Lynch and HCA Healthcare founder Thomas F. Frist Jr. The total transaction was valued at approximately $33 billion, making it the largest leveraged buyout in history at the time, eclipsing the 1989 buyout of RJR Nabisco.

In May 2010, HCA announced that the corporation would once again go public with an expected $4.6-billion IPO as HCA Holdings, Inc. In March 2011, HCA sold 126.2 million shares for $30 each, raising about $3.79 billion, at that time, the largest private-equity backed IPO in U.S. history. In May 2017, the corporation was renamed HCA Healthcare.

In December 2018, a historical marker was installed in the parking lot of HCA's Sarah Cannon Cancer Center in Nashville, formerly the location of HCA's first hospital, Park View Hospital.

In 2018, the company was ranked No. 67 in the 2019 Fortune 500 list of the largest United States corporations by total revenue.

In May 2021, the company finalized a deal with Google to develop healthcare algorithms using patient records. In August 2021, HCA announced a deal with venture capital firm General Catalyst to develop digital solutions to streamline workflows and improve patient care; as part of the deal, HCA sold its healthcare app development firm PatientKeeper to General Catalyst's portfolio company Commure.

In April 2022, HCA Healthcare announced a $1.5 million partnership with Florida International University's Nicole Wertheim college of Nursing and Health Sciences, to expand its facilities to address the national nursing shortage.

In October 2022, LCMC Health in partnership with Tulane University announced that it would acquire Tulane Medical Center, Lakeview Regional Medical Center, and Tulane Lakeside Hospital from HCA for $150 million pending regulatory approval.

In March 2024, it was announced HCA had completed the sale of West Hills Hospital and Medical Center and related assets in Los Angeles, California to UCLA Health, for an undisclosed amount.

Facilities

United States

As of 2024, HCA has 186 hospitals. They also report operating more than 2,400 additional sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics located in 20 U.S. states and in the United Kingdom. A significant portion of those hospitals are situated in Florida and Texas. As of 2022, HCA had 47 hospitals and 31 surgery centers in Florida, and 45 hospitals and 632 affiliated sites of care in Texas. In 2021, it announced plans to build 3 new hospitals in Florida. In 2022, The Dallas Morning News reported that HCA will build 5 new hospitals in Texas. They also have a strong presence in Tennessee, where it began. HCA had 13 hospitals there as of 2019.

Between 2003 and 2017, HCA did not enter any new markets. However, in July 2007, HCA sold its hospitals in Switzerland.

In 2017, HCA acquired the Memorial University Medical Center in Savannah, Georgia. That same year, they acquired three Houston, Texas, hospitals from Tenet Healthcare.

In 2019 they purchased Mission Health System which operates hospitals in North Carolina.

In January 2020, HCA Healthcare acquired Valify, a healthcare cost-management company. In May 2020, HCA acquired 49-bed Shands Starke (Fla.) Regional Medical Center and 25-bed Shands Live Oak (Fla.) Regional Medical Center from CHS. HCA is operating the two facilities as off-campus emergency departments of Lake City (Fla.) Medical Center and North Florida Regional Medical Center in Gainesville. Later that year, it signed an agreement to sell Garden Park Medical Center to Singing River Health System.

In 2021, HCA sold Redmond Regional Medical Center to AdventHealth for $635M, and four other Georgia hospitals to Piedmont Healthcare for $950 million. They also announced the acquisition of Meadows Regional Medical Center.

United Kingdom

HCA International, the UK arm of Hospital Corporation of America, "caters for around half of all private patients in London." The main hospital sites within the United Kingdom it operates include:

It opened urgent care walk-in centres at London Bridge Hospital and the Portland Hospital in March 2018. It claims that patients, on average, wait just seven minutes to see a nurse and 17 minutes to see a doctor. In February 2022, outsourced cleaning staff at London Bridge Hospital reported a lack of PPE, no access to sick pay, a lack of training and no prior warning about which rooms may be contaminated with the virus through the COVID-19 pandemic.

The Princess Grace Hospital specializes in breast cancer and surgery, aided by Kefah Mokbel and Nick Perry who, in 2005, founded The London Breast Institute.

The company opened The Harborne Hospital, a newly built private hospital located close to the Queen Elizabeth Hospital, Birmingham, in February 2024.

Significant areas of operation

Medical education

In recent years, HCA Healthcare has become a significant provider of clinical and medical education. It is the largest sponsor of graduate medical education programs in the U.S., with 56 teaching hospitals in 14 states, primarily in regions with a deficit of physician training programs. The company includes Research College of Nursing and Mercy School of Nursing, and has several advanced nursing simulation training centers. In early 2020, it completed the purchase of a majority stake in Galen College of Nursing, which operates 21 campuses in 12 states, offering Bachelor of Science and Associate of Science nursing degrees.

Controversies

Medicare billing practices lawsuit

In 1993, lawsuits were filed against HCA by former employees who alleged that the company had engaged in questionable Medicare billing practices. In 1997, with a federal investigation by the FBI, the IRS and the Department of Health and Human Services in its early stages, the Columbia/HCA board of directors forced Rick Scott to resign as chairman and CEO amid growing evidence that the company "had kept two sets of books, one to show the government and one with actual expenses listed." Thomas Frist, a co-founder of HCA and brother of U.S. Senator Bill Frist, returned to the company as CEO in 1997 and called on longtime friend and colleague Jack O. Bovender Jr. to help him turn the company around.

The federal probe culminated in 2003 with "the government receiving a total of over $2 billion in criminal fines and civil penalties for systematically defrauding federal health care programs." Columbia/HCA pleaded guilty to 14 felonies and admitted to systematically overcharging the government. The federal probe has been referred to as the longest and costliest investigation for health-care fraud in U.S. history.

2005 insider trading suit

In July 2005, U.S. Senator Bill Frist sold all of his HCA shares, which were held in a blind trust, two weeks before disappointing earnings sent the stock on a 9-point plunge. At the time, Frist was considering a run for president and said that he had sold his shares to avoid the appearance of a conflict of interest. When the company disclosed that other executives had also sold their shares during that same time, shareholders alleged that the company had made false claims about its profits to drive up the price, which then fell when the company reported disappointing financial results. Eleven of HCA's senior officers were sued for accounting fraud and insider trading. HCA settled the lawsuit in August 2007, agreeing to pay $20 million to the shareholders but admitting no wrongdoing, and no charges were brought.

COVID-19 PPE

During the COVID-19 pandemic in the United States, HCA hospital nurses and other workers spoke out about the lack of PPE. In April 2020, there was an outcry against HCA following the deaths of two nurses Celia Yap-Banago and Rosa Luna who worked at HCA hospitals in Kansas City and California and had contracted coronavirus, despite the alarm having been raised about the lack of PPE at work.

Mission Hospital Acquisition Complaints

On December 14, 2023, the North Carolina Attorney General sued HCA for violating the terms of an agreement that allowed HCA to purchase Mission Health.

On February 13, 2024, HCA Healthcare denied the allegations and asked a judge to dismiss the lawsuit by the Attorney General, and in return the hospital network filed a counterclaim against the Attorney General.

Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗

Wikidata ↗

HCA Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas

Preço
$420.53
Capitalização de Mercado
$94.45B
P/E (TTM)
14.8
EPS (TTM)
$28.33
Receita (TTM)
$75.60B
Rendimento div.
0.72%
ROE
-159.1%
Dívida/Capital
-6.9
Intervalo 52 Semanas
$354 – $557

HCA Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização

Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS

Receita e Lucro Líquido $75.60B
10-point trend, +82.2%
2016-12-31 2025-12-31
EPS $28.33
10-point trend, +288.1%
2016-12-31 2025-12-31
Fluxo de caixa livre $7.69B
10-point trend, +165.9%
2016-12-31 2025-12-31
Margens 9.0%

Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?

Métrica
Tendência de 5 anos
HCA
Mediana de Pares
P/E (TTM)
5-point trend, +35.7%
14.8
20.3
P/S (TTM)
5-point trend, +3.8%
1.2
1.1
P/B
5-point trend, +79.3%
-15.7
4.5
EV / EBITDA
5-point trend, +5.5%
38.3
Price / FCF (Preço / FCF)
5-point trend, -6.5%
12.3

Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC

Métrica
Tendência de 5 anos
HCA
Mediana de Pares
Net Profit Margin (Margem de Lucro Líquido)
5-point trend, -24.2%
9.0%
7.4%
ROA
5-point trend, -20.3%
11.3%
6.6%
ROE
5-point trend, +95.9%
-159.1%
23.2%

Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial

Métrica
Tendência de 5 anos
HCA
Mediana de Pares
Debt / Equity (Dívida / Patrimônio Líquido)
5-point trend, +81.4%
-6.9
Current Ratio (Índice de liquidez corrente)
5-point trend, -31.7%
1.0
1.2
Quick Ratio (Índice de Liquidez Seca)
5-point trend, -26.9%
0.7

Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos

Métrica
Tendência de 5 anos
HCA
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
5-point trend, +28.7%
7.1%
Revenue CAGR 3Y (CAGR Receita 3A)
5-point trend, +28.7%
7.9%
Revenue CAGR 5Y (CAGR Receita 5A)
5-point trend, +28.7%
8.0%
EPS YoY
5-point trend, +33.9%
28.8%
Net Income YoY (Lucro Líquido Ano a Ano)
5-point trend, -2.5%
17.8%

Métricas por Ação EPS, valor patrimonial por ação, fluxo de caixa por ação, dividendo por ação

Métrica
Tendência de 5 anos
HCA
Mediana de Pares
EPS (Diluted) (EPS (Diluído))
5-point trend, +33.9%
$28.33

Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber

Métrica
Tendência de 5 anos
HCA
Mediana de Pares
Payout Ratio (Índice de Pagamento)
5-point trend, +11.6%
10.0%

Dividendos Rendimento, índice de pagamento, histórico de dividendos, CAGR de 5 anos

Dividend Yield
0.72%
Índice de Pagamento
10.0%
CAGR Dividendos 5 anos
Data exValor
16 de Junho de 2026$0,7800
17 de Março de 2026$0,7800
15 de Dezembro de 2025$0,7200
16 de Setembro de 2025$0,7200
16 de Junho de 2025$0,7200
17 de Março de 2025$0,7200
13 de Dezembro de 2024$0,6600
16 de Setembro de 2024$0,6600
14 de Junho de 2024$0,6600
14 de Março de 2024$0,6600
13 de Dezembro de 2023$0,6000
14 de Setembro de 2023$0,6000
15 de Junho de 2023$0,6000
16 de Março de 2023$0,6000
13 de Dezembro de 2022$0,5600
15 de Setembro de 2022$0,5600
15 de Junho de 2022$0,5600
16 de Março de 2022$0,5600
13 de Dezembro de 2021$0,4800
15 de Setembro de 2021$0,4800

HCA Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta

COMPRA 30 analistas
  • Compra forte 6 20,0%
  • Compra 11 36,7%
  • Manter 12 40,0%
  • Venda 1 3,3%
  • Venda forte 0 0,0%

Preço-alvo de 12 meses

21 analistas · 2026-08-17
Alvo mediano $450.00 +7,0%
Alvo médio $454.57 +8,1%

Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados

Surpresa Média
0.49%
Período EPS Actual EPS est. Surpresa
30 de Junho de 2026 $7.62 $7.54 0.08%
31 de Março de 2026 $7.15 $7.21 -0.06%
31 de Dezembro de 2025 $8.14 $7.53 0.61%
30 de Setembro de 2025 $6.96 $5.77 1.2%
30 de Junho de 2025 $6.83 $6.31 0.52%
31 de Março de 2025 $6.45 $5.84 0.61%

Comparação de pares (subindústria GICS) Métricas chave vs pares do setor

Ticker Capitalização de Mercado P/E Receita YoY Margem Líquida ROE Margem Bruta
HCA $104.86B 16.5 7.1% 9.0% -159.1%
THC $17.28B 12.8 3.1% 11.1% 56.4%
EHC $10.61B 19.2 10.5% 9.5% 25.1%
ENSG $10.12B 29.8 18.7% 6.8% 16.9%
UHS 9.4 9.7% 8.6% 21.4%
PACS $6.01B 31.5 29.3% 3.6% 23.1%
CON $2.53B 15.1 13.9% 7.7% 49.8%
BKD $2.57B -9.6 2.2% -8.2% -313.2% 26.2%
ACHC $1.28B -1.2 5.0% -33.3% -43.9%
SNDA $612M -7.7 25.2% -18.6% -197.2%

Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa

Demonstração de Resultados 12
Dados anuais de Demonstração de Resultados para HCA
Métrica Tendência 2025202420232022202120202019201820172016
Revenue 10-point trend, +82.2% $75.60B $70.60B $64.97B $60.23B $58.75B $51.53B $51.34B $46.68B $43.61B $41.49B
SG&A Expense 10-point trend, +59.8% $548M $421M $353M $307M $337M $416M $370M $344M $340M $343M
Operating Expenses 10-point trend, +79.3% $65.77B $62.08B $57.26B $51.65B $48.92B $46.10B $46.09B $41.34B $39.23B $36.68B
Interest Expense 10-point trend, +31.7% $2.25B $2.06B $1.94B $1.74B $1.57B $1.58B $1.82B $1.75B $1.69B $1.71B
Pretax Income 10-point trend, +104.4% $9.83B $8.52B $7.71B $8.58B $9.83B $5.43B $5.24B $5.33B $4.38B $4.81B
Income Tax 10-point trend, +48.8% $2.05B $1.87B $1.61B $1.75B $2.11B $1.04B $1.10B $946M $1.64B $1.38B
Net Income 10-point trend, +134.7% $6.78B $5.76B $5.24B $5.64B $6.96B $3.75B $3.50B $3.79B $2.22B $2.89B
EPS (Basic) 10-point trend, +281.1% $28.70 $22.27 $19.25 $19.43 $21.52 $11.10 $10.27 $10.90 $6.12 $7.53
EPS (Diluted) 10-point trend, +288.1% $28.33 $22.00 $18.97 $19.15 $21.16 $10.93 $10.07 $10.66 $5.95 $7.30
Shares (Basic) 10-point trend, -38.4% 236,413,000 258,603,000 272,404,000 290,348,000 323,315,000 338,274,000 341,210,000 347,297,000 362,305,000 383,591,000
Shares (Diluted) 10-point trend, -39.5% 239,495,000 261,806,000 276,412,000 294,666,000 328,752,000 343,605,000 348,226,000 355,303,000 372,221,000 395,851,000
EBITDA 10-point trend, +79.2% $3.52B $3.31B $3.08B $2.97B $2.85B $2.72B $2.60B $2.28B $2.13B $1.97B
Balanço Patrimonial 22
Dados anuais de Balanço Patrimonial para HCA
Métrica Tendência 2025202420232022202120202019201820172016
Cash & Equivalents 10-point trend, +61.0% $1.04B $1.93B $935M $908M $1.45B $1.79B $621M $502M $732M $646M
Short-term Investments 5-point trend, +136.7% · · · · · $116M $147M $47M $54M $49M
Receivables 10-point trend, +86.5% $10.87B $10.75B $9.96B $8.89B $8.10B $7.05B $7.38B $6.79B $6.50B $5.83B
Inventory 10-point trend, +9.9% $1.65B $1.74B $2.02B $2.07B $1.99B $2.02B $1.85B $1.73B $1.57B $1.50B
Other Current Assets 10-point trend, +100.2% $2.22B $1.99B $2.01B $1.78B $2.01B $1.46B $1.35B $1.19B $1.17B $1.11B
Current Assets 10-point trend, +73.7% $15.78B $16.41B $14.93B $13.64B $13.54B $12.33B $11.20B $10.21B $9.98B $9.09B
PP&E (Net) 10-point trend, +90.4% $31.14B $29.41B $27.71B $25.57B $24.06B $23.20B $22.71B $19.76B $17.89B $16.35B
PP&E (Gross) 10-point trend, +78.9% $66.28B $62.51B $58.55B $54.76B $51.35B $49.32B $47.23B $42.97B $40.08B $37.05B
Accum. Depreciation 10-point trend, +69.7% $35.13B $33.10B $30.83B $29.18B $27.29B $26.12B $24.52B $23.21B $22.19B $20.70B
Other Non-current Assets 10-point trend, -76.3% $255M $230M $184M $298M $598M $546M $480M $690M $710M $1.07B
Total Assets 10-point trend, +79.9% $60.72B $59.51B $56.21B $52.44B $50.74B $47.49B $45.06B $39.21B $36.59B $33.76B
Accounts Payable 10-point trend, +101.0% $4.66B $4.28B $4.23B $4.24B $4.11B $3.54B $2.90B $2.58B $2.61B $2.32B
Current Liabilities 10-point trend, +180.3% $16.35B $15.18B $12.65B $9.90B $9.58B $8.70B $7.76B $7.57B $6.16B $5.83B
Capital Leases 7-point trend, +23.6% $1.85B $1.86B $1.90B $1.75B $1.75B $1.67B $1.50B · · ·
Total Liabilities 4-point trend, +15.8% · · · · · · $45.62B $42.12B $41.59B $39.39B
Long-term Debt 10-point trend, +41.1% $44.28B $43.03B $39.59B $38.08B $34.58B $31.00B $33.72B $32.82B $33.06B $31.38B
Total Debt 10-point trend, +32.6% $41.60B $43.03B $39.59B $38.08B $34.58B $31.00B $33.72B $32.82B $33.06B $31.38B
Retained Earnings 10-point trend, +17.9% $-5.72B $-2.12B $-1.35B $-2.28B $-532M $777M $-2.35B $-4.57B $-6.53B $-6.97B
AOCI 10-point trend, +9.8% $-305M $-387M $-425M $-490M $-404M $-502M $-460M $-381M $-278M $-338M
Stockholders' Equity 10-point trend, +17.5% $-6.03B $-2.50B $-1.77B $-2.77B $-933M $572M $-2.81B $-4.95B $-6.81B $-7.30B
Liabilities + Equity 10-point trend, +79.9% $60.72B $59.51B $56.21B $52.44B $50.74B $47.49B $45.06B $39.21B $36.59B $33.76B
Shares Outstanding 10-point trend, -39.4% 224,605,100 249,981,400 265,537,300 277,378,300 305,476,800 339,425,600 338,445,600 342,895,200 350,091,600 370,535,900
Fluxo de Caixa 17
Dados anuais de Fluxo de Caixa para HCA
Métrica Tendência 2025202420232022202120202019201820172016
D&A 10-point trend, +79.2% $3.52B $3.31B $3.08B $2.97B $2.85B $2.72B $2.60B $2.28B $2.13B $1.97B
Stock-based Comp 10-point trend, +59.8% $401M $360M $262M $341M $440M $362M $347M $268M $270M $251M
Amort. of Intangibles 6-point trend, -53.8% $12M $16M $20M $44M $25M $26M · · · ·
Other Non-cash 10-point trend, +172.2% $1.93B $1.08B $850M $-431M $-1.29B $2.40B $1.07B $461M $-3.53B $-2.67B
Operating Cash Flow 10-point trend, +123.5% $12.64B $10.51B $9.43B $8.52B $8.96B $9.23B $7.60B $6.76B $5.43B $5.65B
CapEx 10-point trend, +79.1% $4.94B $4.88B $4.74B $4.39B $3.58B $2.83B $4.16B $3.57B $3.02B $2.76B
Investing Cash Flow 10-point trend, -54.0% $-4.99B $-4.93B $-5.32B $-3.39B $-2.64B $-3.39B $-5.72B $-3.90B $-4.28B $-3.24B
Debt Issued 10-point trend, +56.9% $8.47B $7.50B $3.22B $6.00B $4.34B $2.70B $6.45B $2.00B $1.50B $5.40B
Net Debt Issued 10-point trend, +17.3% $1.08B $5.08B $2.31B $3.17B $475M $-737M $1.13B $296M $749M $925M
Stock Repurchased 10-point trend, +265.9% $10.07B $6.04B $3.81B $7.00B $8.21B $441M $1.03B $1.53B $2.05B $2.75B
Net Stock Activity 10-point trend, -265.9% $-10.07B $-6.04B $-3.81B $-7.00B $-8.21B $-441M $-1.03B $-1.53B $-2.05B $-2.75B
Dividends Paid 9-point trend, +679000000.00 $679M $690M $661M $653M $624M $153M $550M $487M $0 ·
Financing Cash Flow 10-point trend, -240.9% $-8.55B $-4.58B $-4.09B $-5.66B $-6.66B $-4.68B $-1.77B $-3.08B $-1.06B $-2.51B
Net Change in Cash 10-point trend, -840.0% $-893M $998M $27M $-543M $-342M $1.17B $119M $-230M $86M $-95M
Taxes Paid 10-point trend, +38.6% $1.74B $1.84B $1.39B $1.18B $2.18B $1.00B $849M $872M $1.21B $1.25B
Free Cash Flow 10-point trend, +165.9% $7.69B $5.64B $4.69B $4.13B $5.38B $6.40B $3.44B $3.19B $2.41B $2.89B
Levered FCF 10-point trend, +253.0% $5.91B $4.03B $3.16B $2.74B $4.15B $5.12B $2.00B $1.74B $1.35B $1.68B
Lucratividade 5
Dados anuais de Lucratividade para HCA
Métrica Tendência 2025202420232022202120202019201820172016
Net Margin 8-point trend, +10.6% 9.0% 8.2% 8.1% 9.4% 11.8% 7.3% 6.8% 8.1% · ·
Pretax Margin 8-point trend, +13.8% 13.0% 12.1% 11.9% 14.2% 16.7% 10.5% 10.2% 11.4% · ·
EBITDA Margin 8-point trend, -4.5% 4.7% 4.7% 4.7% 4.9% 4.9% 5.3% 5.1% 4.9% · ·
ROA 10-point trend, +29.8% 11.3% 10.0% 9.7% 10.9% 14.2% 8.1% 8.3% 10.0% 6.3% 8.7%
ROE 10-point trend, -310.3% -159.1% -269.6% -230.9% -305.0% -3853.7% -335.8% -90.4% -64.4% -31.4% -38.8%
Liquidez e Solvência 4
Dados anuais de Liquidez e Solvência para HCA
Métrica Tendência 2025202420232022202120202019201820172016
Current Ratio 10-point trend, -38.0% 1.0 1.1 1.2 1.4 1.4 1.4 1.4 1.3 1.6 1.6
Quick Ratio 10-point trend, -34.8% 0.7 0.8 0.9 1.0 1.0 1.0 1.1 1.0 1.2 1.1
Debt / Equity 10-point trend, -60.6% -6.9 -17.2 -22.3 -13.8 -37.1 54.2 -12.0 -6.6 -4.9 -4.3
LT Debt / Equity 10-point trend, -61.8% -6.9 -15.3 -21.0 -13.6 -36.8 53.8 -12.0 -6.5 -4.8 -4.3
Eficiência 2
Dados anuais de Eficiência para HCA
Métrica Tendência 2025202420232022202120202019201820172016
Asset Turnover 8-point trend, +2.1% 1.3 1.2 1.2 1.2 1.2 1.1 1.2 1.2 · ·
Receivables Turnover 8-point trend, -0.4% 7.0 6.8 6.9 7.1 7.8 7.1 7.2 7.0 · ·
Por Ação 6
Dados anuais de Por Ação para HCA
Métrica Tendência 2025202420232022202120202019201820172016
Book Value / Share 10-point trend, -36.2% $-26.83 $-10.00 $-6.68 $-9.98 $-3.05 $1.69 $-8.30 $-14.44 $-19.44 $-19.71
Revenue / Share 8-point trend, +140.3% $315.66 $269.68 $235.04 $204.41 $178.71 $149.98 $147.42 $131.37 · ·
Cash Flow / Share 10-point trend, +269.5% $52.76 $40.16 $34.12 $28.92 $27.25 $26.87 $21.83 $19.03 $14.58 $14.28
Cash / Share 10-point trend, +165.6% $4.63 $7.73 $3.52 $3.27 $4.75 $5.28 $1.83 $1.46 $2.09 $1.74
Dividend / Share 8-point trend, +105.7% $3 $3 $2 $2 $2 $0 $2 $1 · ·
EPS (TTM) 10-point trend, +288.1% $28.33 $22.00 $18.97 $19.15 $21.16 $10.93 $10.07 $10.66 $5.95 $7.30
Taxas de Crescimento 10
Dados anuais de Taxas de Crescimento para HCA
Métrica Tendência 2025202420232022202120202019201820172016
Revenue YoY 5-point trend, -49.5% 7.1% 8.7% 7.9% 2.5% 14.0% · · · · ·
Revenue CAGR 3Y 3-point trend, -2.0% 7.9% 6.3% 8.0% · · · · · · ·
Revenue CAGR 5Y 8.0% · · · · · · · · ·
EPS YoY 5-point trend, -69.3% 28.8% 16.0% -0.94% -9.5% 93.6% · · · · ·
EPS CAGR 3Y 3-point trend, -30.9% 13.9% 1.3% 20.2% · · · · · · ·
EPS CAGR 5Y 21.0% · · · · · · · · ·
Net Income YoY 5-point trend, -79.2% 17.8% 9.9% -7.1% -18.9% 85.3% · · · · ·
Net Income CAGR 3Y 3-point trend, -46.2% 6.3% -6.1% 11.8% · · · · · · ·
Net Income CAGR 5Y 12.6% · · · · · · · · ·
Dividend CAGR 5Y 34.7% · · · · · · · · ·
Avaliação (TTM) 17
Dados anuais de Avaliação (TTM) para HCA
Métrica Tendência 2025202420232022202120202019201820172016
Revenue TTM 10-point trend, +82.2% $75.60B $70.60B $64.97B $60.23B $58.75B $51.53B $51.34B $46.68B $43.61B $41.49B
Net Income TTM 10-point trend, +134.7% $6.78B $5.76B $5.24B $5.64B $6.96B $3.75B $3.50B $3.79B $2.22B $2.89B
Market Cap 10-point trend, +282.3% $104.86B $75.03B $71.88B $66.56B $78.48B $55.82B $50.03B $42.67B $30.75B $27.43B
Enterprise Value 10-point trend, +150.3% $145.42B $116.13B $110.53B $103.74B $111.61B $84.92B $82.98B $74.95B $63.02B $58.11B
P/E 10-point trend, +62.5% 16.5 13.6 14.3 12.5 12.1 15.0 14.7 11.7 14.8 10.1
P/S 10-point trend, +109.8% 1.4 1.1 1.1 1.1 1.3 1.1 1.0 0.9 0.7 0.7
P/B 10-point trend, -363.2% -17.4 -30.0 -40.5 -24.1 -84.1 97.6 -17.8 -8.6 -4.5 -3.8
P / Tangible Book · · · · · 97.6 · · · ·
P / Cash Flow 10-point trend, +71.0% 8.3 7.1 7.6 7.8 8.8 6.0 6.6 6.3 5.7 4.9
P / FCF 10-point trend, +43.8% 13.6 13.3 15.3 16.1 14.6 8.7 14.5 13.4 12.8 9.5
EV / EBITDA 10-point trend, +39.7% 41.3 35.1 35.9 34.9 39.1 31.2 32.0 32.9 29.6 29.6
EV / FCF 10-point trend, -5.9% 18.9 20.6 23.6 25.1 20.7 13.3 24.1 23.5 26.1 20.1
EV / Revenue 10-point trend, +37.4% 1.9 1.6 1.7 1.7 1.9 1.6 1.6 1.6 1.4 1.4
Dividend Yield 9-point trend, +0.01 0.65% 0.92% 0.92% 0.98% 0.80% 0.27% 1.1% 1.1% 0.00% ·
Earnings Yield 10-point trend, -38.4% 6.1% 7.3% 7.0% 8.0% 8.2% 6.7% 6.8% 8.6% 6.8% 9.9%
Payout Ratio 8-point trend, -22.2% 10.0% 12.0% 12.6% 11.6% 9.0% 4.1% 15.7% 12.9% · ·
Annual Payout 9-point trend, +679000000.00 $679M $690M $661M $653M $624M $153M $550M $487M $0 ·

Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos

Demonstração de Resultados
2025-12-312024-12-312023-12-312022-12-312021-12-31
Receita $75.60B$70.60B$64.97B$60.23B$58.75B
Lucro líquido $6.78B$5.76B$5.24B$5.64B$6.96B
EPS Diluído $28.33$22.00$18.97$19.15$21.16
Balanço Patrimonial
2025-12-312024-12-312023-12-312022-12-312021-12-31
Dívida / Patrimônio Líquido -6.9-17.2-22.3-13.8-37.1
Índice de liquidez corrente 1.01.11.21.41.4
Índice de Liquidez Seca 0.70.80.91.01.0
Fluxo de Caixa
2025-12-312024-12-312023-12-312022-12-312021-12-31
Fluxo de caixa livre $7.69B$5.64B$4.69B$4.13B$5.38B

Últimas notícias Notícias recentes mencionando esta empresa

Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos

📊

Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.

Sua seleção é salva e acompanha você em todos os tickers.

Investidores institucionais (13F) 1.486 declarantes · $39.4B total · Em 30 de Junho de 2026

Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.

Atividade institucional — Q2 2026 vs trimestre anterior
Novas posições Posições encerradas Aumentou Diminuído Variação líquida de ações
128 (-51 vs trimestre anterior) 174 (+70 vs trimestre anterior) 450 (-30 vs trimestre anterior) 555 (-4 vs trimestre anterior) +16.3M

Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.

Instituição Valor Ações % de 13F rastreado Tipo
VANGUARD GROUP INC $6.118.113.464 13.104.814 15,52% Ações
VANGUARD CAPITAL MANAGEMENT LLC $3.954.150.533 10.141.708 10,03% Ações
Sanders Capital, LLC $3.442.060.818 8.828.287 8,73% Ações
STATE STREET CORP $2.912.102.056 7.469.035 7,39% Ações
WELLINGTON MANAGEMENT GROUP LLP $1.750.298.867 4.489.212 4,44% Ações
GEODE CAPITAL MANAGEMENT, LLC $1.225.259.672 3.159.159 3,11% Ações
VANGUARD PORTFOLIO MANAGEMENT LLC $1.057.704.509 2.712.828 2,68% Ações
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $861.456.107 2.209.485 2,19% Ações
NORGES BANK $836.457.140 2.145.367 2,12% Ações
Capital World Investors $770.864.224 1.977.121 1,96% Ações
Capital International Investors $747.403.041 1.916.947 1,90% Ações
Crake Asset Management LLP $449.072.183 1.151.792 1,14% Ações
Metropolis Capital Ltd $430.915.307 910.564 1,09% Ações
Darsana Capital Partners LP $428.879.000 1.100.000 1,09% Ações
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $414.533.777 1.063.207 1,05% Ações
Life Cycle Investment Partners Ltd $355.737.196 912.404 0,90% Ações
VANGUARD FIDUCIARY TRUST CO $339.685.814 871.235 0,86% Ações
FMR LLC $325.199.295 834.080 0,83% Ações
BARCLAYS PLC $299.888.573 769.162 0,76% Ações
LYRICAL ASSET MANAGEMENT LP $255.015.742 654.071 0,65% Ações
BlackRock, Inc. $240.062.291 615.718 0,61% Ações
ROYAL LONDON ASSET MANAGEMENT LTD $235.649.908 604.401 0,60% Ações
National Pension Service $230.650.346 591.578 0,59% Ações
NORDEA INVESTMENT MANAGEMENT AB $230.189.125 594.466 0,58% Ações
GOLDMAN SACHS GROUP INC $209.775.669 538.038 0,53% Ações
Gobi Capital LLC $195.742.325 502.045 0,50% Ações
Cryder Capital Partners LLP $194.561.738 499.017 0,49% Ações
Swiss National Bank $172.097.446 441.400 0,44% Ações
AustralianSuper Pty Ltd $159.635.782 409.438 0,41% Ações
Consulta Ltd $155.956.000 400.000 0,40% Ações
LEE DANNER & BASS INC $152.150.679 390.240 0,39% Ações
SUSQUEHANNA INTERNATIONAL GROUP, LLP $151.472.265 388.500 0,38% Opção de compra
Mitsubishi UFJ Asset Management Co., Ltd. $147.943.761 379.450 0,38% Ações
DIMENSIONAL FUND ADVISORS LP $139.697.405 358.300 0,35% Ações
Vanguard Global Advisers, LLC $136.962.509 351.285 0,35% Ações
VIRGINIA RETIREMENT SYSTEMS ET Al $134.838.505 288.820 0,34% Ações
ALLIANCEBERNSTEIN L.P. $134.459.788 284.126 0,34% Ações
Sumitomo Mitsui Trust Group, Inc. $132.794.974 340.596 0,34% Ações
TD Asset Management Inc $131.847.152 338.165 0,33% Ações
Legal & General Group Plc $127.805.162 327.798 0,32% Ações
California Public Employees Retirement System $124.133.958 318.382 0,31% Ações
LAZARD ASSET MANAGEMENT LLC $120.619.879 309.369 0,31% Ações
JANE STREET GROUP, LLC $119.540.274 306.600 0,30% Opção de compra
VANGUARD ASSET MANAGEMENT, Ltd $116.069.863 297.699 0,29% Ações
CAPTRUST FINANCIAL ADVISORS $114.741.071 294.291 0,29% Ações
ANTIPODES PARTNERS Ltd $113.045.096 289.941 0,29% Ações
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $109.718.328 231.845 0,28% Ações
CITADEL ADVISORS LLC $105.660.190 271.000 0,27% Opção de compra
RHUMBLINE ADVISERS $97.580.413 250.277 0,25% Ações
O'SHAUGHNESSY ASSET MANAGEMENT, LLC $97.026.076 248.855 0,25% Ações
MACKENZIE FINANCIAL CORP $93.597.383 240.061 0,24% Ações
BloombergSen Inc. $93.160.317 238.940 0,24% Ações
SUSQUEHANNA INTERNATIONAL GROUP, LLP $92.247.974 236.600 0,23% Opção de venda
Brandywine Global Investment Management, LLC $89.380.814 191.451 0,23% Ações
BANK OF AMERICA CORP /DE/ $89.069.981 228.449 0,23% Ações
NEUBERGER BERMAN GROUP LLC $85.926.216 220.386 0,22% Ações
MILFORD FUNDS LTD $82.165.029 210.739 0,21% Ações
Bridgewater Associates, LP $79.227.208 203.204 0,20% Ações
Prana Capital Management, LP $75.552.494 193.779 0,19% Ações
DANSKE BANK A/S $73.238.497 187.844 0,19% Ações
FRANKLIN RESOURCES INC $70.965.828 182.015 0,18% Ações
VOLORIDGE INVESTMENT MANAGEMENT, LLC $70.445.715 180.681 0,18% Ações
Quantinno Capital Management LP $70.407.055 180.581 0,18% Ações
ARGENT CAPITAL MANAGEMENT LLC $69.149.681 177.357 0,18% Ações
Retirement Systems of Alabama $68.081.812 174.618 0,17% Ações
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND $66.167.842 169.709 0,17% Ações
BNP PARIBAS FINANCIAL MARKETS $64.793.090 166.183 0,16% Ações
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $64.665.206 165.855 0,16% Ações
HSBC HOLDINGS PLC $64.431.534 165.332 0,16% Ações
AVIVA PLC $64.264.789 164.828 0,16% Ações
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $64.194.533 135.649 0,16% Ações
SEB Asset Management AB $63.257.255 162.244 0,16% Ações
TODD ASSET MANAGEMENT LLC $62.567.208 160.474 0,16% Ações
Swedbank AB $62.528.998 160.376 0,16% Ações
W1M Investment Management Ltd $61.247.490 143.647 0,16% Ações
HARRIS ASSOCIATES L P $60.080.879 154.097 0,15% Ações
Ensign Peak Advisors, Inc $58.372.381 149.715 0,15% Ações
NEW YORK STATE COMMON RETIREMENT FUND $57.747.778 148.113 0,15% Ações
CITADEL ADVISORS LLC $57.235.852 146.800 0,15% Opção de venda
Universal- Beteiligungs- und Servicegesellschaft mbH $57.160.993 146.800 0,15% Ações
LOS ANGELES CAPITAL MANAGEMENT LLC $56.512.217 144.944 0,14% Ações
Pictet Asset Management Holding SA $52.147.803 133.739 0,13% Ações
VICTORY CAPITAL MANAGEMENT INC $50.752.761 130.172 0,13% Ações
Pentwater Capital Management LP $50.685.700 130.000 0,13% Ações
D. E. Shaw & Co., Inc. $50.554.307 129.663 0,13% Ações
APG Asset Management N.V. $50.368.550 147.699 0,13% Ações
AMF Tjanstepension AB $50.355.853 129.154 0,13% Ações
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $50.349.225 129.137 0,13% Ações
EQUITABLE TRUST CO $49.147.974 126.056 0,12% Ações
ENVESTNET ASSET MANAGEMENT INC $48.919.124 125.469 0,12% Ações
CANADA PENSION PLAN INVESTMENT BOARD $48.197.812 123.619 0,12% Ações
AMERICAN CENTURY COMPANIES INC $47.460.140 121.727 0,12% Ações
OpenArc Corporate Advisory, LLC $47.210.610 121.087 0,12% Ações
L1 Capital International Pty Ltd $46.121.648 118.294 0,12% Ações
FIRST TRUST ADVISORS LP $44.251.579 113.498 0,11% Ações
PFA Pension, Forsikringsaktieselskab $44.046.098 112.971 0,11% Ações
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund $43.830.264 112.417 0,11% Ações
EP Wealth Advisors, LLC $43.287.826 111.026 0,11% Ações
WOLVERINE TRADING, LLC $42.597.104 101.200 0,11% Opção de compra
MERCER GLOBAL ADVISORS INC /ADV $42.302.070 108.497 0,11% Ações

Executivos da empresa 91 insiders · 54 diretores · 31 conselheiros

Investidor com informação privilegiada Função Última atividade Ações detidas Compras 12m Vendas 12m Líquido 12m
Samuel N Hazen CEO 10 de Fevereiro de 2026 F 64.842 0 7 $-21.483.290
O'Boyle Michael P President & CEO - Parallon 26 de Fevereiro de 2013 A 21.429 0 0 $0
Mike A Marks EVP and CFO 7 de Maio de 2026 G 46.576 0 0 $0
Bill B Rutherford CFO and EVP 16 de Fevereiro de 2024 F 22.251 0 0 $0
Russell K Harms CFO - Central Group 17 de Novembro de 2006 D 0 0 0 $0
Robert Samuel Hankins JR CFO-Outpatient Services Group 17 de Novembro de 2006 D 0 0 0 $0
Richard J Shallcross CFO - Western Group 17 de Novembro de 2006 D 0 0 0 $0
Jeffrey T Crudele CFO-Eastern Division 1 de Julho de 2005 F 13.865 0 0 $0
Erol R Akdamar Group President 12 de Novembro de 2024 M 6.843 0 0 $0
Timothy M Mcmanus Group President 31 de Julho de 2024 M 27.008 0 0 $0
Richard A Hammett Group President 16 de Fevereiro de 2024 F 17.936 0 0 $0
Charles J Hall Group President 11 de Novembro de 2022 M 202.443 0 0 $0
Bruce A Moore JR Group President - Service Line 11 de Novembro de 2022 S 30.807 0 0 $0
Paul W Rutledge Group President 31 de Dezembro de 2012 A 335.657 0 0 $0
Beverly B Wallace President - Parallon 2 de Novembro de 2011 M 144.714 0 0 $0
Charles Robert Evans President - Eastern Group 26 de Julho de 2006 A 62.173 0 0 $0
Marilyn B Tavenner President-Outpatient Svcs Grp 27 de Outubro de 2005 A 26.154 0 0 $0
Greg Roth President-Ambulatory Surgery 31 de Outubro de 2004 D 9.029 0 0 $0
Jay Grinney President-Eastern Group 7 de Maio de 2004 D 24.177 0 0 $0
Jon M Foster EVP and COO 10 de Fevereiro de 2026 F 23.062 0 0 $0
Michael R Mcalevey EVP & Chief Legal & Admin Off. 13 de Fevereiro de 2026 M 8.853 0 2 $-2.747.520
Jennifer Berres SVP & Chief Human Res. Officer 11 de Fevereiro de 2026 S 11.993 0 2 $-4.126.932
Christopher F. Wyatt SVP & Controller 11 de Fevereiro de 2026 S 44.379 0 1 $-2.020.000
Erica Rossitto SVP & Chief Nurse Executive 10 de Fevereiro de 2026 F 10.407 0 0 $0
Michael S. Cuffe EVP and Chief Clinical Officer 10 de Fevereiro de 2026 F 32.080 0 1 $-747.135
Sammie S Mosier SVP & Chief Nurse Executive 13 de Fevereiro de 2025 F 11.113 0 0 $0
Kathleen M Whalen SVP & Chief Ethics Officer 14 de Novembro de 2024 S 9.454 0 0 $0
Phillip G Billington SVP-Internal Audit Services 12 de Novembro de 2024 M 52.702 0 0 $0
Joseph A Sowell III SVP; Chief Development Officer 5 de Agosto de 2024 G 18.526 0 0 $0
Deborah M Reiner SVP - Mktg. & Communications 29 de Julho de 2024 S 3.510 0 0 $0
Kathryn A. Torres SVP-Payer Contracting & Align. 25 de Julho de 2024 S 17.755 0 0 $0
Jeffrey E. Cohen SVP-Government Relations 9 de Maio de 2024 S 5.185 0 0 $0
Chad J Wasserman SVP and CIO 18 de Março de 2024 M 1.576 0 0 $0
Martin P. Paslick SVP and CIO 12 de Abril de 2023 M 24.643 0 0 $0
Jane D. Englebright SVP and Chief Nursing Officer 9 de Novembro de 2021 S 0 0 0 $0
Robert A Waterman SVP & General Counsel 5 de Maio de 2021 S 50.062 0 0 $0
William J Morrow SVP - Finance and Treasurer 18 de Fevereiro de 2021 F 5.578 0 0 $0
Sandra L. Morgan SVP-Provider Relations 18 de Fevereiro de 2021 F 10.122 0 0 $0
Victor L Campbell SVP-Government Affairs 1 de Maio de 2019 A 194.145 0 0 $0
John M Steele SVP & Chief Human Res. Officer 25 de Fevereiro de 2019 M 84.157 0 0 $0
Milton R Johnson Chairman 25 de Fevereiro de 2019 M 881.823 0 0 $0
Ravi S. Chari SVP-Clinical Excellence 25 de Fevereiro de 2018 M 7.003 0 0 $0
Alan R Yuspeh SVP & Chief Ethics Officer 25 de Fevereiro de 2018 M 35.546 0 0 $0
Joseph N Steakley SVP-Internal Audit Services 25 de Fevereiro de 2018 M 65.199 0 0 $0
Jana Joustra Davis SVP - Mktg. & Corp. Affairs 23 de Maio de 2017 M 26.378 0 0 $0
David Gwin Anderson SVP - Finance 7 de Novembro de 2016 M 110.167 0 0 $0
Donald W Stinnett SVP & Controller 25 de Fevereiro de 2016 A 51.965 0 0 $0
Noel B Williams SVP and CIO 16 de Maio de 2012 M 299.030 0 0 $0
Jack O Bovender JR Chairman 6 de Outubro de 2009 A 188.340 0 0 $0
Carl V George SVP - Development 27 de Fevereiro de 2009 M 13.092 0 0 $0

Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto

Ativistas e proprietários de 5%+ 4 participações

Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.

Declarante Declarado Participação Status Propósito Declaração
Frisco Holding II, Hercules Holding II, Thomas F. Frist, Jr., Thomas F. Frist III, William R. Frist, Patricia F. Elcan 10 de Fevereiro de 2026 31,60% Declaração inicial SEC
22 de Novembro de 2006 Declaração inicial SEC
Merrill Lynch Bank USA 11 de Setembro de 2006 Declaração inicial SEC
Frisco, Inc., Frisco Partners, Thomas F. Frist, Jr., Patricia Champion Frist, Patricia Frist Elcan, William Robert Frist, Thomas F. Frist III, Merrill Lynch Professional Clearing Corp., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Merrill Lynch Financial Markets, Inc., Merrill Lynch International, Merrill Lynch & Co., Inc., Merrill Lynch Trust Company, FSB, Citigroup Inc.*, Bank of America Corporation, NB Holdings Corporation, NationsBanc Montgomery Holdings Corporation, Banc of America Securities LLC 4 de Agosto de 2006 Declaração inicial SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Participação em ETFs Detido por 207 ETFs

O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.

Fundo Peso Unidades Em Fonte
IHF · iShares Trust 4,67% 141.320 SH 8 de Agosto de 2026 Diário
BUL · Pacer Funds Trust 3,91% 11.437 NS 30 de Abril de 2026 N-PORT
YALL · Tidal Trust I 3,61% 9.261 NS 31 de Maio de 2026 N-PORT
BWTG · ETF Opportunities Trust 3,02% 1.646 NS 31 de Maio de 2026 N-PORT
PKW · Invesco Exchange-Traded Fund Trust 2,32% 99.335 SH 8 de Agosto de 2026 Diário
ABIG · EA Series Trust 2,00% 2.938 NS 29 de Maio de 2026 N-PORT
FXH · First Trust Exchange-Traded AlphaDE… 1,99% 39.985 NS 30 de Abril de 2026 N-PORT
RSPH · Invesco Exchange-Traded Fund Trust 1,67% 31.685 SH 8 de Agosto de 2026 Diário
COWZ · Pacer Funds Trust 1,64% 688.264 NS 30 de Abril de 2026 N-PORT
QQWZ · Pacer Funds Trust 1,64% 1.762 NS 30 de Abril de 2026 N-PORT
FEGE · RBB Fund Trust 1,46% 74.706 NS 31 de Maio de 2026 N-PORT
PWV · Invesco Exchange-Traded Fund Trust 1,39% 60.385 SH 8 de Agosto de 2026 Diário
RPG · Invesco Exchange-Traded Fund Trust 1,30% 63.448 SH 8 de Agosto de 2026 Diário
TMFE · RBB Fund, Inc. 1,29% 2.892 NS 31 de Maio de 2026 N-PORT
AMID · EA Series Trust 1,23% 3.402 NS 29 de Maio de 2026 N-PORT
FCPI · FIDELITY COVINGTON TRUST 1,15% 7.180 NS 30 de Abril de 2026 N-PORT
FMAG · FIDELITY COVINGTON TRUST 1,12% 6.544 NS 30 de Abril de 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 1,12% 73.639 NS 30 de Abril de 2026 N-PORT
SRHQ · Elevation Series Trust 1,10% 4.883 NS 30 de Abril de 2026 N-PORT
IYH · iShares Trust 0,99% 89.420 SH 8 de Agosto de 2026 Diário
NEAR · iShares U.S. ETF Trust 0,99% 48.109.000 SH 8 de Agosto de 2026 Diário
CURE · Direxion Shares ETF Trust 0,98% 3.122 NS 30 de Abril de 2026 N-PORT
VHT · VANGUARD WORLD FUND 0,90% 470.451 SH 8 de Agosto de 2026 Diário
NFRA · FlexShares Trust 0,88% 62.176 NS 30 de Abril de 2026 N-PORT
REVS · Columbia ETF Trust I 0,87% 5.693 NS 30 de Abril de 2026 N-PORT
RXL · ProShares Trust 0,86% 1.632 NS 31 de Maio de 2026 N-PORT
DIVB · iShares Trust 0,85% 36.806 SH 8 de Agosto de 2026 Diário
BSCT · Invesco Exchange-Traded Self-Indexe… 0,82% 24.078.000 8 de Agosto de 2026 Diário
LSEQ · Harbor ETF Trust 0,81% 285 NS 30 de Abril de 2026 N-PORT
IXJ · iShares Trust 0,80% 81.465 SH 8 de Agosto de 2026 Diário
BSCS · Invesco Exchange-Traded Self-Indexe… 0,76% 26.493.000 8 de Agosto de 2026 Diário
SPVM · Invesco Exchange-Traded Fund Trust 0,74% 2.335 SH 8 de Agosto de 2026 Diário
FTC · First Trust Exchange-Traded AlphaDE… 0,73% 21.329 NS 30 de Abril de 2026 N-PORT
RFFC · ALPS ETF Trust 0,68% 533 NS 31 de Maio de 2026 N-PORT
QUVU · Hartford Funds Exchange-Traded Trust 0,68% 2.698 NS 30 de Abril de 2026 N-PORT
VFMF · VANGUARD WELLINGTON FUND 0,67% 12.075 SH 8 de Agosto de 2026 Diário
VCEB · VANGUARD WORLD FUND 0,62% 8.146.000 PA 8 de Agosto de 2026 Diário
FDMO · FIDELITY COVINGTON TRUST 0,61% 11.771 NS 30 de Abril de 2026 N-PORT
RECS · Columbia ETF Trust I 0,58% 72.768 NS 30 de Abril de 2026 N-PORT
AFLG · First Trust Exchange-Traded Fund VI… 0,56% 9.664 NS 31 de Maio de 2026 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0,55% 11.876 SH 8 de Agosto de 2026 Diário
VLLU · Harbor ETF Trust 0,54% 54 NS 30 de Abril de 2026 N-PORT
LSVD · ADVISORS' INNER CIRCLE FUND 0,53% 7.404 NS 30 de Abril de 2026 N-PORT
WLDR · Two Roads Shared Trust 0,51% 844 NS 30 de Abril de 2026 N-PORT
VALQ · AMERICAN CENTURY ETF TRUST 0,50% 4.620 NS 31 de Maio de 2026 N-PORT
AKAF · ETF Series Solutions 0,50% 39 NS 31 de Maio de 2026 N-PORT
BSCR · Invesco Exchange-Traded Self-Indexe… 0,50% 22.679.000 8 de Agosto de 2026 Diário
ROUS · Lattice Strategies Trust 0,47% 6.388 NS 30 de Abril de 2026 N-PORT
VCLT · VANGUARD SCOTTSDALE FUNDS 0,46% 54.218.000 PA 8 de Agosto de 2026 Diário
CGGR · Capital Group Growth ETF 0,45% 290.273 NS 31 de Maio de 2026 N-PORT